Abstract

Peritoneal dialysis is a home dialysis therapy in which a fluid known as dialysate is placed into the patient's peritoneal cavity. The standard dialysate consists of a concentrated dextrose solution. Icodextrin is a glucose polymer that can be substituted for dextrose with avoidance of some of the glucose-dependant effects. The efficacy and safety of this compound was evaluated and compared with the standard dialysate solutions. It seems to be well-tolerated overall and may offer benefits in select populations of patients with kidney failure. This seems to be especially relevant in patients with more permeable peritoneal membranes who are known as ‘high-transporters’.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.